Cite
Theilen LH, McNeil RB, Hunter S, et al. Serum Cotinine and Adverse Cardiovascular Outcomes: A Cross-sectional Secondary Analysis of the nuMoM2b Heart Health Study. Am J Perinatol. 2021;doi: 10.1055/a-1580-3155.
Theilen, L. H., McNeil, R. B., Hunter, S., Grobman, W. A., Parker, C. B., Catov, J. M., Pemberton, V. L., Ehrenthal, D. B., Haas, D. M., Hoffman, M. K., Chung, J. H., Mukhtar, F., Arzumanyan, Z., Mercer, B., Parry, S., Saade, G. R., Simhan, H. N., Wapner, R. J., Silver, R. M. (2021). Serum Cotinine and Adverse Cardiovascular Outcomes: A Cross-sectional Secondary Analysis of the nuMoM2b Heart Health Study. American journal of perinatology, . https://doi.org/10.1055/a-1580-3155
Theilen, Lauren H, et al. "Serum Cotinine and Adverse Cardiovascular Outcomes: A Cross-sectional Secondary Analysis of the nuMoM2b Heart Health Study." American journal of perinatology vol. (2021). doi: https://doi.org/10.1055/a-1580-3155
Theilen LH, McNeil RB, Hunter S, Grobman WA, Parker CB, Catov JM, Pemberton VL, Ehrenthal DB, Haas DM, Hoffman MK, Chung JH, Mukhtar F, Arzumanyan Z, Mercer B, Parry S, Saade GR, Simhan HN, Wapner RJ, Silver RM. Serum Cotinine and Adverse Cardiovascular Outcomes: A Cross-sectional Secondary Analysis of the nuMoM2b Heart Health Study. Am J Perinatol. 2021 Aug 06; doi: 10.1055/a-1580-3155. Epub 2021 Aug 06. PMID: 34359079.
Copy
Download .nbib